Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
Gabriel BstehHarald HegenPatrick AltmannMichael AuerKlaus BerekFranziska Di PauliFritz LeutmezerPaulus Stefan RommerSebastian WurthAnne ZinganellTobias ZrzavyFlorian DeisenhammerThomas BergerPublished in: European journal of neurology (2021)
GCIPL, and to a lesser degree pRNFL, thinning predicts disability progression after DMT initiation and may be a useful and accessible biomarker of treatment failure in RMS.